English

ORCHARD THERAPEUTICS PLC

EDGAR

ORTX Quarterly report (10-Q) · filed 2023-11-13

55 filing records in this dataset, filed from 2018-10-04 to 2023-11-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

6.3 million USD

2023 Q3 · USD

Exact inputs and evidence

Revenue: 6302000 USD Source

Operating margin

-342.83%

2023 Q3 · %

Exact inputs and evidence

Operating Income: -21605000 USD Source
Revenue: 6302000 USD Source

Operating cash flow

-23.9 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -81233000 USD Source
Operating Cash Flow: -57341000 USD Source

Free cash flow

-24 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -81233000 USD Source
Operating Cash Flow: -57341000 USD Source
Capital Expenditure: 609000 USD Source
Capital Expenditure: 483000 USD Source

Cash and cash equivalents: 23.5 million USD 2023-09-30 Source
Exact value

23469000 USD
Long-term debt including current maturities: 24.8 million USD 2020-03-31 Source
Exact value

24794000 USD
Shares outstanding: 227 million shares 2023-09-30 Source
Exact value

227273209 shares

Reported share-count change

79.56% · 101 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

126572749 shares · 2022-09-30· Source
227273209 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

21.8 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Revenue: 22655000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 15669000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 1237000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 7314000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 6302000 USD · 2023-07-01 – 2023-09-30 Source

Net income

-72.9 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Net income: -150660000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -142777000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -17412000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -12307000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -35319000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-93.3 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -75987000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -63903000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -29508000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -57341000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -29508000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -81233000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -57341000 USD · 2023-01-01 – 2023-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-13.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2022-12-31
Operating income: 7 of 11 periods available· newest 2022-12-31
Net income: 7 of 11 periods available· newest 2022-12-31
Operating cash flow: 7 of 11 periods available· newest 2022-12-31
Capital expenditure: 7 of 11 periods available· newest 2022-12-31
Total assets: 6 of 11 periods available· newest 2022-12-31
Total liabilities: 6 of 11 periods available· newest 2022-12-31
Current assets: 6 of 11 periods available· newest 2022-12-31
Current liabilities: 6 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2019-12-31
Shares outstanding: 6 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+1,252.5%

Prior period

USD 1.68 million

2021-01-01 – 2021-12-31
Current period

USD 22.66 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

22655000 − 1675000 = 20980000 USD

1675000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
22655000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Year-over-year change in Revenue: 20980000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 22655000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#2767486 Filing: 000095017023007708 Input fundies:Revenue: 1675000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#2769443 Filing: 000095017023007708
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 6.08 million

Prior period

−USD 144.58 million

2021-01-01 – 2021-12-31
Current period

−USD 150.66 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-150660000 − -144584000 = -6076000 USD

-144584000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-150660000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Year-over-year change in Net income: -6076000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -150660000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3120413 Filing: 000095017023007708 Input fundies:NetIncome: -144584000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3015152 Filing: 000095017023007708
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 49.11 million

Prior period

−USD 125.1 million

2021-01-01 – 2021-12-31
Current period

−USD 75.99 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-75987000 − -125097000 = 49110000 USD

-125097000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-75987000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Year-over-year change in Operating cash flow: 49110000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -75987000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3229240 Filing: 000095017023007708 Input fundies:OperatingCashFlow: -125097000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3231499 Filing: 000095017023007708
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+177.4%

Prior period

USD 2.35 million

2021-01-01 – 2021-12-31
Current period

USD 6.51 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

6514000 − 2348000 = 4166000 USD

2348000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
6514000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Year-over-year change in Capital expenditure: 4166000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 6514000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3255227 Filing: 000095017023007708 Input fundies:CapitalExpenditure: 2348000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3257540 Filing: 000095017023007708
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 22.66 million 100% of revenue
Cost of revenue USD 6.77 million 30% of revenue
Operating expenses USD 142.97 million 631% of revenue
Operating income −USD 127.09 million −561% of revenue
Tax, interest and other Derived USD 23.57 million 104% of revenue
Net income −USD 150.66 million −665% of revenue

Cash

Operating cash flow −USD 75.99 million −335% of revenue
Capital expenditure USD 6.51 million 29% of revenue
Free cash flow Derived −USD 82.5 million −364% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Not shown: operating income or net income is not reported.
2018 Operating loss: operating costs were 11,421% of revenue.
2019 Operating loss: operating costs were 6,979% of revenue.
2020 Operating loss: operating costs were 6,149% of revenue.
2021 Operating loss: operating costs were 8,484% of revenue.
2022 Operating loss: operating costs were 661% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	0	38512000 Derived	-38512000	1232000 Derived	-39744000	-34046000 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -38512000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -39744000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -32487000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1559000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	2076000	237107000 Derived	-235031000	-4536000 Derived	-230495000	-101568000 Derived	Source 2018-01-01 – 2018-12-31: 2076000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -235031000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -230495000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -97536000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 4032000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	2513000	175386000 Derived	-172873000	-9451000 Derived	-163422000	-170498000 Derived	Source 2019-01-01 – 2019-12-31: 2513000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -172873000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -163422000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -166131000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 4367000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	2595000	159573000 Derived	-156978000	-4978000 Derived	-152000000	-128942000 Derived	Source 2020-01-01 – 2020-12-31: 2595000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -156978000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -152000000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -126274000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 2668000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1675000	142108000 Derived	-140433000	4151000 Derived	-144584000	-127445000 Derived	Source 2021-01-01 – 2021-12-31: 1675000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -140433000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -144584000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -125097000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 2348000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	22655000	149743000 Derived	-127088000	23572000 Derived	-150660000	-82501000 Derived	Source 2022-01-01 – 2022-12-31: 22655000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -127088000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -150660000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -75987000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 6514000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 22.7M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	2076000	Revenue: 2076000 Open source
20192019-12-31	Revenue	2513000	Revenue: 2513000 Open source
20202020-12-31	Revenue	2595000	Revenue: 2595000 Open source
20212021-12-31	Revenue	1675000	Revenue: 1675000 Open source
20222022-12-31	Revenue	22655000	Revenue: 22655000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

1,252.5% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 2076000 Open source Revenue: 0 Open source
20192019-12-31	Year over year	21.1%	Revenue: 2513000 Open source Revenue: 2076000 Open source
20202020-12-31	Year over year	3.3%	Revenue: 2595000 Open source Revenue: 2513000 Open source
20212021-12-31	Year over year	-35.5%	Revenue: 1675000 Open source Revenue: 2595000 Open source
20222022-12-31	Year over year	1,252.5%	Revenue: 22655000 Open source Revenue: 1675000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -561% 2022

Net margin -665% 2022

Free cash flow margin -364.2% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	Not reported	Operating Income: -38512000 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	-11,321.3%	Operating Income: -235031000 Open source Revenue: 2076000 Open source
20192019-12-31	Operating margin	-6,879.1%	Operating Income: -172873000 Open source Revenue: 2513000 Open source
20202020-12-31	Operating margin	-6,049.2%	Operating Income: -156978000 Open source Revenue: 2595000 Open source
20212021-12-31	Operating margin	-8,384.1%	Operating Income: -140433000 Open source Revenue: 1675000 Open source
20222022-12-31	Operating margin	-561%	Operating Income: -127088000 Open source Revenue: 22655000 Open source
20172017-12-31	Net margin	Not reported	Net Income: -39744000 Open source Revenue: 0 Open source
20182018-12-31	Net margin	-11,102.8%	Net Income: -230495000 Open source Revenue: 2076000 Open source
20192019-12-31	Net margin	-6,503.1%	Net Income: -163422000 Open source Revenue: 2513000 Open source
20202020-12-31	Net margin	-5,857.4%	Net Income: -152000000 Open source Revenue: 2595000 Open source
20212021-12-31	Net margin	-8,631.9%	Net Income: -144584000 Open source Revenue: 1675000 Open source
20222022-12-31	Net margin	-665%	Net Income: -150660000 Open source Revenue: 22655000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -32487000 Open source Capital Expenditure: 1559000 Open source
20182018-12-31	Free cash flow margin	-4,892.5%	Revenue: 2076000 Open source Operating Cash Flow: -97536000 Open source Capital Expenditure: 4032000 Open source
20192019-12-31	Free cash flow margin	-6,784.6%	Revenue: 2513000 Open source Operating Cash Flow: -166131000 Open source Capital Expenditure: 4367000 Open source
20202020-12-31	Free cash flow margin	-4,968.9%	Revenue: 2595000 Open source Operating Cash Flow: -126274000 Open source Capital Expenditure: 2668000 Open source
20212021-12-31	Free cash flow margin	-7,608.7%	Revenue: 1675000 Open source Operating Cash Flow: -125097000 Open source Capital Expenditure: 2348000 Open source
20222022-12-31	Free cash flow margin	-364.2%	Revenue: 22655000 Open source Operating Cash Flow: -75987000 Open source Capital Expenditure: 6514000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -76M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-32487000	Operating Cash Flow: -32487000 Open source
20182018-12-31	Operating cash flow	-97536000	Operating Cash Flow: -97536000 Open source
20192019-12-31	Operating cash flow	-166131000	Operating Cash Flow: -166131000 Open source
20202020-12-31	Operating cash flow	-126274000	Operating Cash Flow: -126274000 Open source
20212021-12-31	Operating cash flow	-125097000	Operating Cash Flow: -125097000 Open source
20222022-12-31	Operating cash flow	-75987000	Operating Cash Flow: -75987000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -82.5M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-34046000	Operating Cash Flow: -32487000 Open source Capital Expenditure: 1559000 Open source
20182018-12-31	Free cash flow	-101568000	Operating Cash Flow: -97536000 Open source Capital Expenditure: 4032000 Open source
20192019-12-31	Free cash flow	-170498000	Operating Cash Flow: -166131000 Open source Capital Expenditure: 4367000 Open source
20202020-12-31	Free cash flow	-128942000	Operating Cash Flow: -126274000 Open source Capital Expenditure: 2668000 Open source
20212021-12-31	Free cash flow	-127445000	Operating Cash Flow: -125097000 Open source Capital Expenditure: 2348000 Open source
20222022-12-31	Free cash flow	-82501000	Operating Cash Flow: -75987000 Open source Capital Expenditure: 6514000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

55.1% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	11.2%	Total Liabilities: 10889000 Open source Total Assets: 97294000 Open source
20182018-12-31	Liabilities / assets	14.9%	Total Liabilities: 54704000 Open source Total Assets: 366042000 Open source
20192019-12-31	Liabilities / assets	25.1%	Total Liabilities: 100088000 Open source Total Assets: 399281000 Open source
20202020-12-31	Liabilities / assets	36.5%	Total Liabilities: 102503000 Open source Total Assets: 280937000 Open source
20212021-12-31	Liabilities / assets	34.9%	Total Liabilities: 112459000 Open source Total Assets: 322409000 Open source
20222022-12-31	Liabilities / assets	55.1%	Total Liabilities: 120643000 Open source Total Assets: 218907000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.78× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	8.76×	Current Assets: 94221000 Open source Current Liabilities: 10755000 Open source
20182018-12-31	Current assets / current liabilities	7.42×	Current Assets: 355517000 Open source Current Liabilities: 47905000 Open source
20192019-12-31	Current assets / current liabilities	6.26×	Current Assets: 349896000 Open source Current Liabilities: 55856000 Open source
20202020-12-31	Current assets / current liabilities	4.34×	Current Assets: 223535000 Open source Current Liabilities: 51561000 Open source
20212021-12-31	Current assets / current liabilities	6.43×	Current Assets: 275321000 Open source Current Liabilities: 42793000 Open source
20222022-12-31	Current assets / current liabilities	2.78×	Current Assets: 168145000 Open source Current Liabilities: 60567000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 19.09 million Exact value Exact value: -19085000 USD 2016-01-01 – 2016-12-31: -19085000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORCHARD THERAPEUTICS PLC · 2016-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Net Income: -19085000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19085000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459019008892/ortx-20181231.xml#156998 Filing: 000156459019008892 The citation records this snapshot. The page link may show a newer release later.	−USD 14.57 million Exact value Exact value: -14566000 USD 2016-01-01 – 2016-12-31: -14566000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORCHARD THERAPEUTICS PLC · 2016-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Operating Cash Flow: -14566000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14566000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459019008892/ortx-20181231.xml#190391 Filing: 000156459019008892 The citation records this snapshot. The page link may show a newer release later.	USD 190,000 Exact value Exact value: 190000 USD 2016-01-01 – 2016-12-31: 190000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORCHARD THERAPEUTICS PLC · 2016-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Capital Expenditure: 190000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 190000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459019008892/ortx-20181231.xml#191023 Filing: 000156459019008892 The citation records this snapshot. The page link may show a newer release later.	−USD 14.76 million Calculation and evidence -14566000 − 190000 USD Exact free cash flow: -14756000 USD 2016-01-01 – 2016-12-31: -14566000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 190000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORCHARD THERAPEUTICS PLC · 2016-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Free cash flow: -14756000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14566000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459019008892/ortx-20181231.xml#190391 Filing: 000156459019008892 Input fundies:CapitalExpenditure: 190000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459019008892/ortx-20181231.xml#191023 Filing: 000156459019008892 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 39.74 million Exact value Exact value: -39744000 USD 2017-01-01 – 2017-12-31: -39744000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORCHARD THERAPEUTICS PLC · 2017-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Net Income: -39744000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39744000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#164365 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.	−USD 32.49 million Exact value Exact value: -32487000 USD 2017-01-01 – 2017-12-31: -32487000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORCHARD THERAPEUTICS PLC · 2017-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Operating Cash Flow: -32487000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32487000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#202295 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.	USD 1.56 million Exact value Exact value: 1559000 USD 2017-01-01 – 2017-12-31: 1559000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORCHARD THERAPEUTICS PLC · 2017-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Capital Expenditure: 1559000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1559000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#203355 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.	−USD 34.05 million Calculation and evidence -32487000 − 1559000 USD Exact free cash flow: -34046000 USD 2017-01-01 – 2017-12-31: -32487000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1559000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORCHARD THERAPEUTICS PLC · 2017-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Free cash flow: -34046000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32487000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#202295 Filing: 000156459020007353 Input fundies:CapitalExpenditure: 1559000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#203355 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 230.5 million Exact value Exact value: -230495000 USD 2018-01-01 – 2018-12-31: -230495000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORCHARD THERAPEUTICS PLC · 2018-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Net Income: -230495000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -230495000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#164210 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.	−USD 97.54 million Exact value Exact value: -97536000 USD 2018-01-01 – 2018-12-31: -97536000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORCHARD THERAPEUTICS PLC · 2018-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Operating Cash Flow: -97536000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -97536000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#202083 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.	USD 4.03 million Exact value Exact value: 4032000 USD 2018-01-01 – 2018-12-31: 4032000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORCHARD THERAPEUTICS PLC · 2018-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Capital Expenditure: 4032000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4032000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#203145 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.	−USD 101.57 million Calculation and evidence -97536000 − 4032000 USD Exact free cash flow: -101568000 USD 2018-01-01 – 2018-12-31: -97536000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 4032000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORCHARD THERAPEUTICS PLC · 2018-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Free cash flow: -101568000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -97536000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#202083 Filing: 000156459020007353 Input fundies:CapitalExpenditure: 4032000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459020007353/ortx-20191231.xml#203145 Filing: 000156459020007353 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 163.42 million Exact value Exact value: -163422000 USD 2019-01-01 – 2019-12-31: -163422000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORCHARD THERAPEUTICS PLC · 2019-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Net Income: -163422000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -163422000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459021010035/ortx-10k_20201231.htm#4435929 Filing: 000156459021010035 The citation records this snapshot. The page link may show a newer release later.	−USD 166.13 million Exact value Exact value: -166131000 USD 2019-01-01 – 2019-12-31: -166131000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORCHARD THERAPEUTICS PLC · 2019-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Operating Cash Flow: -166131000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -166131000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459021010035/ortx-10k_20201231.htm#2954480 Filing: 000156459021010035 The citation records this snapshot. The page link may show a newer release later.	USD 4.37 million Exact value Exact value: 4367000 USD 2019-01-01 – 2019-12-31: 4367000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORCHARD THERAPEUTICS PLC · 2019-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Capital Expenditure: 4367000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4367000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459021010035/ortx-10k_20201231.htm#2977677 Filing: 000156459021010035 The citation records this snapshot. The page link may show a newer release later.	−USD 170.5 million Calculation and evidence -166131000 − 4367000 USD Exact free cash flow: -170498000 USD 2019-01-01 – 2019-12-31: -166131000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 4367000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORCHARD THERAPEUTICS PLC · 2019-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Free cash flow: -170498000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -166131000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459021010035/ortx-10k_20201231.htm#2954480 Filing: 000156459021010035 Input fundies:CapitalExpenditure: 4367000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459021010035/ortx-10k_20201231.htm#2977677 Filing: 000156459021010035 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 152 million Exact value Exact value: -152000000 USD 2020-01-01 – 2020-12-31: -152000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORCHARD THERAPEUTICS PLC · 2020-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Net Income: -152000000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -152000000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459022012325/ortx-10k_20211231.htm#3054890 Filing: 000156459022012325 The citation records this snapshot. The page link may show a newer release later.	−USD 126.27 million Exact value Exact value: -126274000 USD 2020-01-01 – 2020-12-31: -126274000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORCHARD THERAPEUTICS PLC · 2020-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Operating Cash Flow: -126274000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -126274000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459022012325/ortx-10k_20211231.htm#2933133 Filing: 000156459022012325 The citation records this snapshot. The page link may show a newer release later.	USD 2.67 million Exact value Exact value: 2668000 USD 2020-01-01 – 2020-12-31: 2668000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORCHARD THERAPEUTICS PLC · 2020-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Capital Expenditure: 2668000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2668000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459022012325/ortx-10k_20211231.htm#2960199 Filing: 000156459022012325 The citation records this snapshot. The page link may show a newer release later.	−USD 128.94 million Calculation and evidence -126274000 − 2668000 USD Exact free cash flow: -128942000 USD 2020-01-01 – 2020-12-31: -126274000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 2668000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORCHARD THERAPEUTICS PLC · 2020-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Free cash flow: -128942000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -126274000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459022012325/ortx-10k_20211231.htm#2933133 Filing: 000156459022012325 Input fundies:CapitalExpenditure: 2668000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000156459022012325/ortx-10k_20211231.htm#2960199 Filing: 000156459022012325 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 144.58 million Exact value Exact value: -144584000 USD 2021-01-01 – 2021-12-31: -144584000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORCHARD THERAPEUTICS PLC · 2021-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Net Income: -144584000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -144584000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3015152 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.	−USD 125.1 million Exact value Exact value: -125097000 USD 2021-01-01 – 2021-12-31: -125097000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORCHARD THERAPEUTICS PLC · 2021-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Operating Cash Flow: -125097000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -125097000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3231499 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.	USD 2.35 million Exact value Exact value: 2348000 USD 2021-01-01 – 2021-12-31: 2348000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORCHARD THERAPEUTICS PLC · 2021-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Capital Expenditure: 2348000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2348000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3257540 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.	−USD 127.45 million Calculation and evidence -125097000 − 2348000 USD Exact free cash flow: -127445000 USD 2021-01-01 – 2021-12-31: -125097000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 2348000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORCHARD THERAPEUTICS PLC · 2021-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Free cash flow: -127445000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -125097000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3231499 Filing: 000095017023007708 Input fundies:CapitalExpenditure: 2348000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3257540 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 150.66 million Exact value Exact value: -150660000 USD 2022-01-01 – 2022-12-31: -150660000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Net Income: -150660000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -150660000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3120413 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.	−USD 75.99 million Exact value Exact value: -75987000 USD 2022-01-01 – 2022-12-31: -75987000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Operating Cash Flow: -75987000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -75987000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3229240 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.	USD 6.51 million Exact value Exact value: 6514000 USD 2022-01-01 – 2022-12-31: 6514000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Capital Expenditure: 6514000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6514000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3255227 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.	−USD 82.5 million Calculation and evidence -75987000 − 6514000 USD Exact free cash flow: -82501000 USD 2022-01-01 – 2022-12-31: -75987000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 6514000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORCHARD THERAPEUTICS PLC · 2022-12-31 ORCHARD THERAPEUTICS PLC (edgar:1748907) Free cash flow: -82501000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:36:39Z Snapshot: 034defaebd26fbfccce2d7238af28efecb084c3da804834da08cc50b846aa661 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1748907?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -75987000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3229240 Filing: 000095017023007708 Input fundies:CapitalExpenditure: 6514000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1748907/000095017023007708/ortx-20221231.htm#3255227 Filing: 000095017023007708 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

55 filings · 1,684 latest values · 1,684 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001748907, 1748907, ORTX, edgar:1748907

Also known as ORCHARD THERAPEUTICS PLC, Orchard Rx Ltd, Orchard Therapeutics plc

ORCHARD THERAPEUTICS PLC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation